文献速递复苏、休克与脓毒症心脑血管急症

心肺复苏期间应用M101细胞外血红蛋白:一项实验性啮齿动物研究

EFFECTS OF M101-AN EXTRACELLULAR HEMOGLOBIN-APPLIED DURING CARDIOPULMONARY RESUSCITATION: AN EXPERIMENTAL RODENT STUDY.
PubMed 文献 · Shock · 2023-04-26
一句话结论大鼠心脏骤停模型中,复苏时给予M101(300 mg/kg)未显著改变脑炎症或脑氧合,仅小脑单一区域磷酸化tau降低(P=0.048),提示可能减轻缺氧性脑损伤。

这项概念验证研究在27只Wistar大鼠中诱导6分钟无收缩性心脏骤停,在开始心肺复苏时同步输注M101(300 mg/kg)或安慰剂(0.9%氯化钠),于自主循环恢复后8小时测量脑氧合及5种炎症与脑损伤生物标志物(来自血液、脑脊液及四个脑区匀浆)。在21项不同测量中,M101组与对照组无显著差异,仅小脑单一区域磷酸化tau降低(P=0.048;所有脑区ANOVA P=0.004)。M101组动脉血压仅在自主循环恢复后4至8分钟显著升高(P<0.001),酸中毒减轻(P=0.009)。作者认为数据提示M101可能减少缺氧性脑损伤、减轻整体缺血负担,但心脏骤停后输注M101能否改善脑氧合尚不清楚,需进一步研究。

要点

  • 在6分钟无收缩性心脏骤停大鼠模型中,复苏开始时同步输注M101 300 mg/kg,未显著改变脑炎症或脑氧合。
  • 21项炎症与脑损伤生物标志物测量中,仅小脑单一区域磷酸化tau在M101组降低(P=0.048),所有脑区ANOVA P=0.004。
  • M101组动脉血压仅在自主循环恢复后4至8分钟显著升高(P<0.001),酸中毒减轻(P=0.009)。
  • 作者认为数据提示M101可能减少缺氧性脑损伤、减轻整体缺血负担。
  • 心脏骤停后输注M101能否改善脑氧合尚不清楚,需进一步研究。

适用人群与场景

  • 接受6分钟无收缩性心脏骤停的Wistar大鼠模型,在开始心肺复苏时同步给药。

处置流程与药物剂量

  • 在开始心肺复苏时同步输注M101 300 mg/kg或安慰剂(0.9%氯化钠)。

研究设计与关键结果

  • 研究类型:概念验证性实验性啮齿动物研究;样本量:27只Wistar大鼠;人群:接受6分钟无收缩性心脏骤停的大鼠;干预与对照:M101 300 mg/kg vs 安慰剂(0.9%氯化钠),均在开始心肺复苏时同步输注。
  • 主要终点结果:在21项不同测量(脑氧合及5种炎症与脑损伤生物标志物,来自血液、脑脊液和四个脑区匀浆)中,M101组与对照组无显著差异,仅小脑单一区域磷酸化tau降低(P=0.048;所有脑区ANOVA P=0.004)。
  • 关键次要终点:动脉血压仅在自主循环恢复后4至8分钟显著升高(P<0.001);酸中毒减轻(P=0.009)。

证据类型、等级与局限

  • 证据类型:实验性啮齿动物研究(概念验证研究)。
  • 局限:作者指出心脏骤停后输注M101能否改善脑氧合尚不清楚,需进一步研究。
  • 局限:原文未报告其他局限性。

对床旁实践的改变

  • 原文未据此给出推荐;作者认为数据提示M101可能减少缺氧性脑损伤、减轻整体缺血负担,但能否改善脑氧合尚不清楚,需进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

During and immediately after cardiac arrest, cerebral oxygen delivery is impaired mainly by microthrombi and cerebral vasoconstriction. This may narrow capillaries so much that it might impede the flow of red blood cells and thus oxygen transport. The aim of this proof-of-concept study was to evaluate the effect of M101, an extracellular hemoglobin-based oxygen carrier (Hemarina SA, Morlaix, France) derived from Arenicola marina , applied during cardiac arrest in a rodent model, on markers of brain inflammation, brain damage, and regional cerebral oxygen saturation. Twenty-seven Wistar rats subjected to 6 min of asystolic cardiac arrest were infused M101 (300 mg/kg) or placebo (NaCl 0.9%) concomitantly with start of cardiopulmonary resuscitation. Brain oxygenation and five biomarkers of inflammation and brain damage (from blood, cerebrospinal fluid, and homogenates from four brain regions) were measured 8 h after return of spontaneous circulation. In these 21 different measurements, M101-treated animals were not significantly different from controls except for phospho-tau only in single cerebellum regions ( P = 0.048; ANOVA of all brain regions: P = 0.004). Arterial blood pressure increased significantly only at 4 to 8 min after return of spontaneous circulation ( P < 0.001) and acidosis decreased ( P = 0.009). While M101 applied during cardiac arrest did not significantly change inflammation or brain oxygenation, the data suggest cerebral damage reduction due to hypoxic brain injury, measured by phospho-tau. Global burden of ischemia appeared reduced because acidosis was less severe. Whether postcardiac arrest infusion of M101 improves brain oxygenation is unknown and needs to be investigated.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Iten M, Glas M, Kindler M, et al. EFFECTS OF M101-AN EXTRACELLULAR HEMOGLOBIN-APPLIED DURING CARDIOPULMONARY RESUSCITATION: AN EXPERIMENTAL RODENT STUDY. Shock. 2023. PMID: 37071071. doi:10.1097/SHK.0000000000002132

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。